Innoviva (NASDAQ:INVA) Earns Hold Rating from Analysts at StockNews.com

StockNews.com assumed coverage on shares of Innoviva (NASDAQ:INVA – Free Report) in a report issued on Thursday morning. The firm issued a hold rating on the biotechnology company’s stock. INVA has been the topic of a number of other reports. EF Hutton Acquisition Co. I restated a buy rating and issued a $22.50 price target […]

Related Keywords

United States ,Alexanderj Denner , ,Securities Exchange Commission ,Ef Hutton Acquisition Co ,Acadian Asset Management ,Advisor Group Holdings Inc ,Cetera Advisor Networks ,Jpmorgan Chase Co ,Innoviva Inc ,York Mellon Corp ,Free Report ,Exchange Commission ,Group Holdings ,New York Mellon Corp ,Advisor Networks ,Asset Management ,Get Free Report ,Innoviva Daily ,Innoviva ,Nasdaq Inva ,Minva ,Medical ,88338t10 ,Initiated Coverage ,Stocknews Com ,